Comment
doi: 10.1016/S1470-2045(12)70030-X.
Epub 2012 Feb 7.
Bone loss associated with prevention of breast cancer
Affiliations
- PMID: 22318094
- DOI: 10.1016/S1470-2045(12)70030-X
Item in Clipboard
Comment
Bone loss associated with prevention of breast cancer
Lancet Oncol.
2012 Mar.
No abstract available
Comment on
-
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.Lancet Oncol. 2012 Mar;13(3):275-84. doi: 10.1016/S1470-2045(11)70389-8. Epub 2012 Feb 7. Lancet Oncol. 2012. PMID: 22318095 Clinical Trial.
Similar articles
-
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.Lancet Oncol. 2012 Mar;13(3):275-84. doi: 10.1016/S1470-2045(11)70389-8. Epub 2012 Feb 7. Lancet Oncol. 2012. PMID: 22318095 Clinical Trial.
-
The breast cancer chemoprevention debate.J Natl Cancer Inst. 2011 Nov 16;103(22):1646-7. doi: 10.1093/jnci/djr479. Epub 2011 Oct 24. J Natl Cancer Inst. 2011. PMID: 22025628 No abstract available.
-
Exemestane or tamoxifen?Lancet. 2007 May 12;369(9573):1600; author reply 1600-1. doi: 10.1016/S0140-6736(07)60741-7. Lancet. 2007. PMID: 17499595 No abstract available.
-
Women and bone health: maximizing the benefits of aromatase inhibitor therapy.Oncology. 2010;79(1-2):13-26. doi: 10.1159/000314997. Epub 2010 Nov 3. Oncology. 2010. PMID: 21051913 Review.
-
[Expert group consensus: prevention, diagnosis and treatment of bone loss and osteoporosis in postmenopausal breast cancer patients after aromatase inhibitor therapy].Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):876-9. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24447490 Chinese. No abstract available.
Cited by
-
Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study.J Bone Oncol. 2021 Dec 29;32:100409. doi: 10.1016/j.jbo.2021.100409. eCollection 2022 Feb. J Bone Oncol. 2021. PMID: 35024328 Free PMC article.
-
Longitudinal changes of trabecular bone score after estrogen deprivation: effect of menopause and aromatase inhibition.J Endocrinol Invest. 2014 Sep;37(9):871-4. doi: 10.1007/s40618-014-0125-2. Epub 2014 Jul 19. J Endocrinol Invest. 2014. PMID: 25037472
-
Aromatase inhibitors-induced bone loss in early breast cancer.Bonekey Rep. 2012 Oct 3;1:201. doi: 10.1038/bonekey.2012.201. eCollection 2012. Bonekey Rep. 2012. PMID: 24936287 Free PMC article.
-
Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis.PLoS One. 2013 Aug 26;8(8):e70044. doi: 10.1371/journal.pone.0070044. eCollection 2013. PLoS One. 2013. PMID: 23990894 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
